These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 12082048)
21. The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Carrieri G; Marzi E; Olivieri F; Marchegiani F; Cavallone L; Cardelli M; Giovagnetti S; Stecconi R; Molendini C; Trapassi C; De Benedictis G; Kletsas D; Franceschi C Aging Cell; 2004 Dec; 3(6):443-8. PubMed ID: 15569360 [TBL] [Abstract][Full Text] [Related]
22. Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease? Lambert JC; Mann D; Richard F; Tian J; Shi J; Thaker U; Merrot S; Harris J; Frigard B; Iwatsubo T; Lendon C; Amouyel P J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):928-33. PubMed ID: 15965197 [TBL] [Abstract][Full Text] [Related]
23. +10 T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution. Arosio B; Bergamaschini L; Galimberti L; La Porta C; Zanetti M; Calabresi C; Scarpini E; Annoni G; Vergani C Mech Ageing Dev; 2007 Oct; 128(10):553-7. PubMed ID: 17889927 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1 genotype in sporadic breast cancer patients from India: status of enhancer, promoter, 5'-untranslated-region and exon-1 polymorphisms. Saha A; Gupta V; Bairwa NK; Malhotra D; Bamezai R Eur J Immunogenet; 2004 Feb; 31(1):37-42. PubMed ID: 15009180 [TBL] [Abstract][Full Text] [Related]
25. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lambert JC; Mann D; Goumidi L; Harris J; Amouyel P; Iwatsubo T; Lendon C; Chartier-Harlin MC Lancet; 2001 Feb; 357(9256):608-9. PubMed ID: 11558492 [TBL] [Abstract][Full Text] [Related]
26. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597 [TBL] [Abstract][Full Text] [Related]
27. Absence of association between transforming growth factor-beta1 promoter polymorphisms and hypodontia. Peres RC; Scarel-Caminaga RM; Silva ER; De Conto F; Line SR Angle Orthod; 2004 Oct; 74(5):665-71. PubMed ID: 15529502 [TBL] [Abstract][Full Text] [Related]
28. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients]. Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330 [TBL] [Abstract][Full Text] [Related]
29. The promoter region (-800, -509) polymorphisms of transforming growth factor-beta1 (TGF-beta1) gene and recurrent spontaneous abortion. Amani D; Zolghadri J; Dehaghani AS; Pezeshki AM; Ghaderi A J Reprod Immunol; 2004 Jun; 62(1-2):159-66. PubMed ID: 15288191 [TBL] [Abstract][Full Text] [Related]
30. Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease. Estrada LD; Oliveira-Cruz L; Cabrera D Curr Protein Pept Sci; 2018; 19(12):1180-1188. PubMed ID: 29189146 [TBL] [Abstract][Full Text] [Related]
31. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients. Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740 [TBL] [Abstract][Full Text] [Related]
32. Association of TGF-beta1 polymorphisms with chronic renal disease. Coll E; Cormand B; Campos B; González-Núñez D; Iñigo P; Botey A; Poch E J Nephrol; 2004; 17(6):794-9. PubMed ID: 15593053 [TBL] [Abstract][Full Text] [Related]
33. TGF-β1 factor in the cerebrovascular diseases of Alzheimer's disease. Zhang X; Huang WJ; Chen WW Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5178-5185. PubMed ID: 28051272 [TBL] [Abstract][Full Text] [Related]